APO Research
Talk to an analyst

APO RESEARCH · REPORT

Aurora Kinase B

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Aurora Kinase B Industry Growth and Trends Forecast to 2032

19 December 202596 pages

Choose your research edition.

Industry ResearchAurora Kinase B Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Aurora Kinase B Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Aurora Kinase B Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Aurora Kinase B Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Aurora Kinase B Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Aurora Kinase B market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Aurora Kinase B is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Aurora Kinase B is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Aurora Kinase B is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Aurora Kinase B include Advenchen Laboratories LLC, Aeterna Zentaris Inc, Chipscreen Biosciences Ltd, Cielo Therapeutics Inc, Sareum Holdings Plc, AstraZeneca Plc, AbbVie Inc, Amgen Inc and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Aurora Kinase B market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Aurora Kinase B market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Aurora Kinase B market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Aurora Kinase B.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Aurora Kinase B market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Aurora Kinase B Market by Company

Advenchen Laboratories LLC

Aeterna Zentaris Inc

Chipscreen Biosciences Ltd

Cielo Therapeutics Inc

Sareum Holdings Plc

AstraZeneca Plc

AbbVie Inc

Amgen Inc

Sanofi

Aurora Kinase B Segment by Type

Danusertib

NMI-900

Ilorasertib

CS-2164

AZD-2811

Others

Aurora Kinase B Segment by Application

Kidney Cancer

Prostate Cancer

Anaplastic Large Cell Lymphoma

Lung Cancer

Others

Aurora Kinase B Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aurora Kinase B market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Aurora Kinase B and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aurora Kinase B.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Aurora Kinase B manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Aurora Kinase B in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Danusertib Table 2. Major Company of NMI-900 Table 3. Major Company of Ilorasertib Table 4. Major Company of CS-2164 Table 5. Major Company of AZD-2811 Table 6. Major Company of Others Table 7. Global Aurora Kinase B Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Aurora Kinase B Sales by Type (2021-2026) & (W Units) Table 9. Global Aurora Kinase B Sales Market Share in Volume by Type (2021-2026) Table 10. Global Aurora Kinase B Sales by Type (2021-2026) & (US$ Million) Table 11. Global Aurora Kinase B Sales Market Share in Value by Type (2021-2026) Table 12. Global Aurora Kinase B Price by Type (2021-2026) & (US$/Unit) Table 13. Global Aurora Kinase B Sales by Type (2027-2032) & (W Units) Table 14. Global Aurora Kinase B Sales Market Share in Volume by Type (2027-2032) Table 15. Global Aurora Kinase B Sales by Type (2027-2032) & (US$ Million) Table 16. Global Aurora Kinase B Sales Market Share in Value by Type (2027-2032) Table 17. Global Aurora Kinase B Price by Type (2027-2032) & (US$/Unit) Table 18. North America Aurora Kinase B Sales by Type (2021-2026) & (W Units) Table 19. North America Aurora Kinase B Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Aurora Kinase B Sales by Type (2021-2026) & (W Units) Table 21. Europe Aurora Kinase B Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Aurora Kinase B Sales by Type (2021-2026) & (W Units) Table 23. Asia-Pacific Aurora Kinase B Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Aurora Kinase B Sales by Type (2021-2026) & (W Units) Table 25. Latin America Aurora Kinase B Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Aurora Kinase B Sales by Type (2021-2026) & (W Units) Table 27. Middle East and Africa Aurora Kinase B Sales by Type (2021-2026) & (US$ Million) Table 28. Aurora Kinase B Industry Trends Table 29. Aurora Kinase B Industry Drivers Table 30. Aurora Kinase B Industry Opportunities and Challenges Table 31. Aurora Kinase B Industry Restraints Table 32. Global Aurora Kinase B Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Aurora Kinase B Revenue Market Share by Company (2021-2026) Table 34. Global Aurora Kinase B Sales by Company (2021-2026) & (W Units) Table 35. Global Aurora Kinase B Sales Share by Company (2021-2026) Table 36. Global Aurora Kinase B Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Aurora Kinase B Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Aurora Kinase B Major Company Production Sites and Headquarters Table 39. Global Aurora Kinase B Company, Product Type & Application Table 40. Global Aurora Kinase B Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Aurora Kinase B by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Aurora Kinase B Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Aurora Kinase B Sales by Region (2021-2026) & (W Units) Table 45. Global Aurora Kinase B Sales Market Share in Volume by Region (2021-2026) Table 46. Global Aurora Kinase B Sales by Region (2021-2026) & (US$ Million) Table 47. Global Aurora Kinase B Sales Market Share in Value by Region (2021-2026) Table 48. Global Aurora Kinase B Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Aurora Kinase B Sales by Region (2027-2032) & (W Units) Table 50. Global Aurora Kinase B Sales Market Share in Volume by Region (2027-2032) Table 51. Global Aurora Kinase B Sales by Region (2027-2032) & (US$ Million) Table 52. Global Aurora Kinase B Sales Market Share in Value by Region (2027-2032) Table 53. Global Aurora Kinase B Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Aurora Kinase B Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Aurora Kinase B Sales by Application (2021-2026) & (W Units) Table 56. Global Aurora Kinase B Sales Market Share in Volume by Application (2021-2026) Table 57. Global Aurora Kinase B Sales by Application (2021-2026) & (US$ Million) Table 58. Global Aurora Kinase B Sales Market Share in Value by Application (2021-2026) Table 59. Global Aurora Kinase B Price by Application (2021-2026) & (US$/Unit) Table 60. Global Aurora Kinase B Sales by Application (2027-2032) & (W Units) Table 61. Global Aurora Kinase B Sales Market Share in Volume by Application (2027-2032) Table 62. Global Aurora Kinase B Sales by Application (2027-2032) & (US$ Million) Table 63. Global Aurora Kinase B Sales Market Share in Value by Application (2027-2032) Table 64. Global Aurora Kinase B Price by Application (2027-2032) & (US$/Unit) Table 65. North America Aurora Kinase B Sales by Application (2021-2026) & (W Units) Table 66. North America Aurora Kinase B Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Aurora Kinase B Sales by Application (2021-2026) & (W Units) Table 68. Europe Aurora Kinase B Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Aurora Kinase B Sales by Application (2021-2026) & (W Units) Table 70. Asia-Pacific Aurora Kinase B Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Aurora Kinase B Sales by Application (2021-2026) & (W Units) Table 72. Latin America Aurora Kinase B Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Aurora Kinase B Sales by Application (2021-2026) & (W Units) Table 74. Middle East and Africa Aurora Kinase B Sales by Application (2021-2026) & (US$ Million) Table 75. Advenchen Laboratories LLC Company Information Table 76. Advenchen Laboratories LLC Business Overview Table 77. Advenchen Laboratories LLC Aurora Kinase B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Advenchen Laboratories LLC Aurora Kinase B Product Portfolio Table 79. Advenchen Laboratories LLC Recent Development Table 80. Aeterna Zentaris Inc Company Information Table 81. Aeterna Zentaris Inc Business Overview Table 82. Aeterna Zentaris Inc Aurora Kinase B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Aeterna Zentaris Inc Aurora Kinase B Product Portfolio Table 84. Aeterna Zentaris Inc Recent Development Table 85. Chipscreen Biosciences Ltd Company Information Table 86. Chipscreen Biosciences Ltd Business Overview Table 87. Chipscreen Biosciences Ltd Aurora Kinase B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Chipscreen Biosciences Ltd Aurora Kinase B Product Portfolio Table 89. Chipscreen Biosciences Ltd Recent Development Table 90. Cielo Therapeutics Inc Company Information Table 91. Cielo Therapeutics Inc Business Overview Table 92. Cielo Therapeutics Inc Aurora Kinase B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Cielo Therapeutics Inc Aurora Kinase B Product Portfolio Table 94. Cielo Therapeutics Inc Recent Development Table 95. Sareum Holdings Plc Company Information Table 96. Sareum Holdings Plc Business Overview Table 97. Sareum Holdings Plc Aurora Kinase B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Sareum Holdings Plc Aurora Kinase B Product Portfolio Table 99. Sareum Holdings Plc Recent Development Table 100. AstraZeneca Plc Company Information Table 101. AstraZeneca Plc Business Overview Table 102. AstraZeneca Plc Aurora Kinase B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. AstraZeneca Plc Aurora Kinase B Product Portfolio Table 104. AstraZeneca Plc Recent Development Table 105. AbbVie Inc Company Information Table 106. AbbVie Inc Business Overview Table 107. AbbVie Inc Aurora Kinase B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. AbbVie Inc Aurora Kinase B Product Portfolio Table 109. AbbVie Inc Recent Development Table 110. Amgen Inc Company Information Table 111. Amgen Inc Business Overview Table 112. Amgen Inc Aurora Kinase B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Amgen Inc Aurora Kinase B Product Portfolio Table 114. Amgen Inc Recent Development Table 115. Sanofi Company Information Table 116. Sanofi Business Overview Table 117. Sanofi Aurora Kinase B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Sanofi Aurora Kinase B Product Portfolio Table 119. Sanofi Recent Development Table 120. North America Aurora Kinase B Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 121. North America Aurora Kinase B Sales by Country (2021-2026) & (W Units) Table 122. North America Aurora Kinase B Sales Market Share by Country (2021-2026) Table 123. North America Aurora Kinase B Sales Forecast by Country (2027-2032) & (W Units) Table 124. North America Aurora Kinase B Sales Market Share Forecast by Country (2027-2032) Table 125. North America Aurora Kinase B Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 126. North America Aurora Kinase B Market Size by Country (2021-2026) & (US$ Million) Table 127. North America Aurora Kinase B Market Share by Country (2021-2026) Table 128. North America Aurora Kinase B Market Size Forecast by Country (2027-2032) & (US$ Million) Table 129. North America Aurora Kinase B Market Share Forecast by Country (2027-2032) Table 130. Europe Aurora Kinase B Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 131. Europe Aurora Kinase B Sales by Country (2021-2026) & (W Units) Table 132. Europe Aurora Kinase B Sales Market Share by Country (2021-2026) Table 133. Europe Aurora Kinase B Sales Forecast by Country (2027-2032) & (W Units) Table 134. Europe Aurora Kinase B Sales Market Share Forecast by Country (2027-2032) Table 135. Europe Aurora Kinase B Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 136. Europe Aurora Kinase B Market Size by Country (2021-2026) & (US$ Million) Table 137. Europe Aurora Kinase B Market Share by Country (2021-2026) Table 138. Europe Aurora Kinase B Market Size Forecast by Country (2027-2032) & (US$ Million) Table 139. Europe Aurora Kinase B Market Share Forecast by Country (2027-2032) Table 140. Asia-Pacific Aurora Kinase B Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 141. Asia-Pacific Aurora Kinase B Sales by Country (2021-2026) & (W Units) Table 142. Asia-Pacific Aurora Kinase B Sales Market Share by Country (2021-2026) Table 143. Asia-Pacific Aurora Kinase B Sales Forecast by Country (2027-2032) & (W Units) Table 144. Asia-Pacific Aurora Kinase B Sales Market Share Forecast by Country (2027-2032) Table 145. Asia-Pacific Aurora Kinase B Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 146. Asia-Pacific Aurora Kinase B Market Size by Country (2021-2026) & (US$ Million) Table 147. Asia-Pacific Aurora Kinase B Market Share by Country (2021-2026) Table 148. Asia-Pacific Aurora Kinase B Market Size Forecast by Country (2027-2032) & (US$ Million) Table 149. Asia-Pacific Aurora Kinase B Market Share Forecast by Country (2027-2032) Table 150. Latin America Aurora Kinase B Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 151. Latin America Aurora Kinase B Sales by Country (2021-2026) & (W Units) Table 152. Latin America Aurora Kinase B Sales Market Share by Country (2021-2026) Table 153. Latin America Aurora Kinase B Sales Forecast by Country (2027-2032) & (W Units) Table 154. Latin America Aurora Kinase B Sales Market Share Forecast by Country (2027-2032) Table 155. Latin America Aurora Kinase B Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 156. Latin America Aurora Kinase B Market Size by Country (2021-2026) & (US$ Million) Table 157. Latin America Aurora Kinase B Market Share by Country (2021-2026) Table 158. Latin America Aurora Kinase B Market Size Forecast by Country (2027-2032) & (US$ Million) Table 159. Latin America Aurora Kinase B Market Share Forecast by Country (2027-2032) Table 160. Middle East and Africa Aurora Kinase B Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 161. Middle East and Africa Aurora Kinase B Sales by Country (2021-2026) & (W Units) Table 162. Middle East and Africa Aurora Kinase B Sales Market Share by Country (2021-2026) Table 163. Middle East and Africa Aurora Kinase B Sales Forecast by Country (2027-2032) & (W Units) Table 164. Middle East and Africa Aurora Kinase B Sales Market Share Forecast by Country (2027-2032) Table 165. Middle East and Africa Aurora Kinase B Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 166. Middle East and Africa Aurora Kinase B Market Size by Country (2021-2026) & (US$ Million) Table 167. Middle East and Africa Aurora Kinase B Market Share by Country (2021-2026) Table 168. Middle East and Africa Aurora Kinase B Market Size Forecast by Country (2027-2032) & (US$ Million) Table 169. Middle East and Africa Aurora Kinase B Market Share Forecast by Country (2027-2032) Table 170. Key Raw Materials Table 171. Raw Materials Key Suppliers Table 172. Aurora Kinase B Distributors List Table 173. Aurora Kinase B Customers List Table 174. Research Programs/Design for This Report Table 175. Authors List of This Report Table 176. Secondary Sources Table 177. Primary Sources List of Figures Figure 1. Aurora Kinase B Image Figure 2. Global Aurora Kinase B Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Aurora Kinase B Market Size (2021-2032) & (US$ Million) Figure 4. Global Aurora Kinase B Sales (2021-2032) & (W Units) Figure 5. Danusertib Image Figure 6. Global Danusertib Sales YoY Growth (2021-2032) & (W Units) Figure 7. NMI-900 Image Figure 8. Global NMI-900 Sales YoY Growth (2021-2032) & (W Units) Figure 9. Ilorasertib Image Figure 10. Global Ilorasertib Sales YoY Growth (2021-2032) & (W Units) Figure 11. CS-2164 Image Figure 12. Global CS-2164 Sales YoY Growth (2021-2032) & (W Units) Figure 13. AZD-2811 Image Figure 14. Global AZD-2811 Sales YoY Growth (2021-2032) & (W Units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 17. Global Aurora Kinase B Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Aurora Kinase B Market Share by Type 2025 VS 2032 Figure 19. North America Aurora Kinase B Sales Market Share in Volume by Type in 2025 Figure 20. North America Aurora Kinase B Sales Market Share in Value by Type in 2025 Figure 21. Europe Aurora Kinase B Sales Market Share in Volume by Type in 2025 Figure 22. Europe Aurora Kinase B Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Aurora Kinase B Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Aurora Kinase B Sales Market Share in Value by Type in 2025 Figure 25. Latin America Aurora Kinase B Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Aurora Kinase B Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Aurora Kinase B Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Aurora Kinase B Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Aurora Kinase B Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Kidney Cancer Image Figure 32. Global Kidney Cancer Sales YoY Growth (2021-2032) & (W Units) Figure 33. Prostate Cancer Image Figure 34. Global Prostate Cancer Sales YoY Growth (2021-2032) & (W Units) Figure 35. Anaplastic Large Cell Lymphoma Image Figure 36. Global Anaplastic Large Cell Lymphoma Sales YoY Growth (2021-2032) & (W Units) Figure 37. Lung Cancer Image Figure 38. Global Lung Cancer Sales YoY Growth (2021-2032) & (W Units) Figure 39. Others Image Figure 40. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 41. Global Aurora Kinase B Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global Aurora Kinase B Market Share by Application 2025 VS 2032 Figure 43. North America Aurora Kinase B Sales Market Share in Volume by Application in 2025 Figure 44. North America Aurora Kinase B Sales Market Share in Value by Application in 2025 Figure 45. Europe Aurora Kinase B Sales Market Share in Volume by Application in 2025 Figure 46. Europe Aurora Kinase B Sales Market Share in Value by Application in 2025 Figure 47. Asia-Pacific Aurora Kinase B Sales Market Share in Volume by Application in 2025 Figure 48. Asia-Pacific Aurora Kinase B Sales Market Share in Value by Application in 2025 Figure 49. Latin America Aurora Kinase B Sales Market Share in Volume by Application in 2025 Figure 50. Latin America Aurora Kinase B Sales Market Share in Value by Application in 2025 Figure 51. Middle East and Africa Aurora Kinase B Sales Market Share in Volume by Application in 2025 Figure 52. Middle East and Africa Aurora Kinase B Sales Market Share in Value by Application in 2025 Figure 53. North America Aurora Kinase B Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. North America Aurora Kinase B Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. North America Aurora Kinase B Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. North America Aurora Kinase B Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Aurora Kinase B Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Europe Aurora Kinase B Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Aurora Kinase B Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Europe Aurora Kinase B Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Aurora Kinase B Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 62. Asia-Pacific Aurora Kinase B Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Aurora Kinase B Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Asia-Pacific Aurora Kinase B Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Aurora Kinase B Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 66. Latin America Aurora Kinase B Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Aurora Kinase B Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Latin America Aurora Kinase B Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Aurora Kinase B Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 70. Middle East and Africa Aurora Kinase B Sales Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Aurora Kinase B Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 72. Middle East and Africa Aurora Kinase B Market Share by Country: 2021 VS 2025 VS 2032 Figure 73. Aurora Kinase B Value Chain Figure 74. Key Raw Materials Price Figure 75. Manufacturing Cost Structure Figure 76. Aurora Kinase B Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • Danusertib
  • NMI-900
  • Ilorasertib
  • CS-2164
  • AZD-2811
  • Others
Applications
  • Kidney Cancer
  • Prostate Cancer
  • Anaplastic Large Cell Lymphoma
  • Lung Cancer
  • Others
Companies covered
  • Advenchen Laboratories LLC
  • Aeterna Zentaris Inc
  • Chipscreen Biosciences Ltd
  • Cielo Therapeutics Inc
  • Sareum Holdings Plc
  • AstraZeneca Plc
  • AbbVie Inc
  • Amgen Inc
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Aurora Kinase B Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Aurora Kinase B Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Aurora Kinase B Market by Type
  6. 1.3.1 Danusertib
  7. 1.3.2 NMI-900
  8. 1.3.3 Ilorasertib
  9. 1.3.4 CS-2164
  10. 1.3.5 AZD-2811
  11. 1.3.6 Others
  12. 1.4 Global Aurora Kinase B Market Size by Type
  13. 1.4.1 Global Aurora Kinase B Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Aurora Kinase B Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Aurora Kinase B Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Aurora Kinase B Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Aurora Kinase B Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Aurora Kinase B Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Aurora Kinase B Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Aurora Kinase B Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Aurora Kinase B Industry Trends
  2. 2.2 Aurora Kinase B Industry Drivers
  3. 2.3 Aurora Kinase B Industry Opportunities and Challenges
  4. 2.4 Aurora Kinase B Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Aurora Kinase B Revenue (2021-2026)
  2. 3.2 Global Top Players by Aurora Kinase B Sales (2021-2026)
  3. 3.3 Global Top Players by Aurora Kinase B Price (2021-2026)
  4. 3.4 Global Aurora Kinase B Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Aurora Kinase B Major Company Production Sites & Headquarters
  6. 3.6 Global Aurora Kinase B Company, Product Type & Application
  7. 3.7 Global Aurora Kinase B Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Aurora Kinase B Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Aurora Kinase B Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Aurora Kinase B Tier 1, Tier 2, and Tier 3
4 Aurora Kinase B Regional Status and Outlook
  1. 4.1 Global Aurora Kinase B Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Aurora Kinase B Historic Market Size by Region
  3. 4.2.1 Global Aurora Kinase B Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Aurora Kinase B Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Aurora Kinase B Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Aurora Kinase B Forecasted Market Size by Region
  7. 4.3.1 Global Aurora Kinase B Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Aurora Kinase B Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Aurora Kinase B Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Aurora Kinase B by Application
  1. 5.1 Aurora Kinase B Market by Application
  2. 5.1.1 Kidney Cancer
  3. 5.1.2 Prostate Cancer
  4. 5.1.3 Anaplastic Large Cell Lymphoma
  5. 5.1.4 Lung Cancer
  6. 5.1.5 Others
  7. 5.2 Global Aurora Kinase B Market Size by Application
  8. 5.2.1 Global Aurora Kinase B Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Aurora Kinase B Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Aurora Kinase B Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Aurora Kinase B Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Aurora Kinase B Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Aurora Kinase B Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Aurora Kinase B Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Aurora Kinase B Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Advenchen Laboratories LLC
  2. 6.1.1 Advenchen Laboratories LLC Company Information
  3. 6.1.2 Advenchen Laboratories LLC Business Overview
  4. 6.1.3 Advenchen Laboratories LLC Aurora Kinase B Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Advenchen Laboratories LLC Aurora Kinase B Product Portfolio
  6. 6.1.5 Advenchen Laboratories LLC Recent Developments
  7. 6.2 Aeterna Zentaris Inc
  8. 6.2.1 Aeterna Zentaris Inc Company Information
  9. 6.2.2 Aeterna Zentaris Inc Business Overview
  10. 6.2.3 Aeterna Zentaris Inc Aurora Kinase B Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Aeterna Zentaris Inc Aurora Kinase B Product Portfolio
  12. 6.2.5 Aeterna Zentaris Inc Recent Developments
  13. 6.3 Chipscreen Biosciences Ltd
  14. 6.3.1 Chipscreen Biosciences Ltd Company Information
  15. 6.3.2 Chipscreen Biosciences Ltd Business Overview
  16. 6.3.3 Chipscreen Biosciences Ltd Aurora Kinase B Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Chipscreen Biosciences Ltd Aurora Kinase B Product Portfolio
  18. 6.3.5 Chipscreen Biosciences Ltd Recent Developments
  19. 6.4 Cielo Therapeutics Inc
  20. 6.4.1 Cielo Therapeutics Inc Company Information
  21. 6.4.2 Cielo Therapeutics Inc Business Overview
  22. 6.4.3 Cielo Therapeutics Inc Aurora Kinase B Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Cielo Therapeutics Inc Aurora Kinase B Product Portfolio
  24. 6.4.5 Cielo Therapeutics Inc Recent Developments
  25. 6.5 Sareum Holdings Plc
  26. 6.5.1 Sareum Holdings Plc Company Information
  27. 6.5.2 Sareum Holdings Plc Business Overview
  28. 6.5.3 Sareum Holdings Plc Aurora Kinase B Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sareum Holdings Plc Aurora Kinase B Product Portfolio
  30. 6.5.5 Sareum Holdings Plc Recent Developments
  31. 6.6 AstraZeneca Plc
  32. 6.6.1 AstraZeneca Plc Company Information
  33. 6.6.2 AstraZeneca Plc Business Overview
  34. 6.6.3 AstraZeneca Plc Aurora Kinase B Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 AstraZeneca Plc Aurora Kinase B Product Portfolio
  36. 6.6.5 AstraZeneca Plc Recent Developments
  37. 6.7 AbbVie Inc
  38. 6.7.1 AbbVie Inc Company Information
  39. 6.7.2 AbbVie Inc Business Overview
  40. 6.7.3 AbbVie Inc Aurora Kinase B Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 AbbVie Inc Aurora Kinase B Product Portfolio
  42. 6.7.5 AbbVie Inc Recent Developments
  43. 6.8 Amgen Inc
  44. 6.8.1 Amgen Inc Company Information
  45. 6.8.2 Amgen Inc Business Overview
  46. 6.8.3 Amgen Inc Aurora Kinase B Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Amgen Inc Aurora Kinase B Product Portfolio
  48. 6.8.5 Amgen Inc Recent Developments
  49. 6.9 Sanofi
  50. 6.9.1 Sanofi Company Information
  51. 6.9.2 Sanofi Business Overview
  52. 6.9.3 Sanofi Aurora Kinase B Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Sanofi Aurora Kinase B Product Portfolio
  54. 6.9.5 Sanofi Recent Developments
7 North America by Country
  1. 7.1 North America Aurora Kinase B Sales by Country
  2. 7.1.1 North America Aurora Kinase B Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Aurora Kinase B Sales by Country (2021-2026)
  4. 7.1.3 North America Aurora Kinase B Sales Forecast by Country (2027-2032)
  5. 7.2 North America Aurora Kinase B Market Size by Country
  6. 7.2.1 North America Aurora Kinase B Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Aurora Kinase B Market Size by Country (2021-2026)
  8. 7.2.3 North America Aurora Kinase B Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Aurora Kinase B Sales by Country
  2. 8.1.1 Europe Aurora Kinase B Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Aurora Kinase B Sales by Country (2021-2026)
  4. 8.1.3 Europe Aurora Kinase B Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Aurora Kinase B Market Size by Country
  6. 8.2.1 Europe Aurora Kinase B Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Aurora Kinase B Market Size by Country (2021-2026)
  8. 8.2.3 Europe Aurora Kinase B Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Aurora Kinase B Sales by Country
  2. 9.1.1 Asia-Pacific Aurora Kinase B Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Aurora Kinase B Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Aurora Kinase B Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Aurora Kinase B Market Size by Country
  6. 9.2.1 Asia-Pacific Aurora Kinase B Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Aurora Kinase B Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Aurora Kinase B Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Aurora Kinase B Sales by Country
  2. 10.1.1 South America Aurora Kinase B Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Aurora Kinase B Sales by Country (2021-2026)
  4. 10.1.3 South America Aurora Kinase B Sales Forecast by Country (2027-2032)
  5. 10.2 South America Aurora Kinase B Market Size by Country
  6. 10.2.1 South America Aurora Kinase B Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Aurora Kinase B Market Size by Country (2021-2026)
  8. 10.2.3 South America Aurora Kinase B Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Aurora Kinase B Sales by Country
  2. 11.1.1 Middle East and Africa Aurora Kinase B Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Aurora Kinase B Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Aurora Kinase B Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Aurora Kinase B Market Size by Country
  6. 11.2.1 Middle East and Africa Aurora Kinase B Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Aurora Kinase B Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Aurora Kinase B Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Aurora Kinase B Value Chain Analysis
  2. 12.1.1 Aurora Kinase B Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Aurora Kinase B Production Mode & Process
  7. 12.2 Aurora Kinase B Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Aurora Kinase B Distributors
  10. 12.2.3 Aurora Kinase B Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst